Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20191121002Completed
Open-label, single-arm trial of meropenem in peritonitis, sponsored by Routine to Research Unit. Primary endpoints: Plasma meropenem concentration at 24 hours and Dialysate meropenem concentration at 24 hours. Started Oct 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20191121002.